Tech Launch Arizona has a new home. The Refinery is the University of Arizona’s new innovation hub located at the University of Arizona Tech Park at The Bridges. Continue reading
Wexford Science & Technology, LLC, a national innovation district developer that partners exclusively with universities, academic medical centers, and research institutions, is launching the Wexford Innovation Labs at 850 PBC, the firm’s newest development located in the Phoenix Bioscience Core. Opening in the fall of 2022, the Wexford Innovation Labs will initially comprise 34,500 square feet of flexible lab, office, and lab support facilities specifically designed to meet the rigorous needs of growing life science companies. These flexible lab spaces are also paired with full-service amenities such as shared lab equipment; weekly networking and educational programming; and flexible terms.Continue reading
Reglagene, NeuroEM, Avery Therapeutics, and OncoMyx Therapeutics will deliver Company Presentations given by senior-level executives at the 2022 BIO International Convention in San Diego. Company Presentations showcase a company’s pipeline, R&D activities, business objectives, and investment goals. Continue reading
A primary challenge in the diagnosis of neurological disorders is differentiating between conditions that share clinical features. Absent of a clear diagnosis, proper and effective patient care is hindered. Therefore, there is a great need for accessible diagnostic tools that help provide clarity to diagnosing clinicians.
Start-Up Stadium provides start-up companies with the opportunity to access key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology event. AZBio congratulates nVector, Inc., BacVax, Inc., and Nixxi for being selected to present at BIO2022.Continue reading
Nurse-led Pilot Funded by The American Nurses Foundation
Phoenix, Arizona, May 24th, 10:00 am MST: Phoenix-based startup Navi Nurses is one of 10 grantees to receive funding from the American Nurses Foundation as part of the Reimagining Nursing Initiative (RN Initiative). The American Nurses Foundation established the RN Initiative to support bold and innovative ideas developed and led by nurses to spark long-term change within health care. Out of the nearly 350 applicants, RN Initiative is supporting the boldest ideas with potential to revolutionize nursing.Continue reading
Thirty-two leaders and experts in technology, innovation, workforce development and academia have been appointed to the National Advisory Council on Innovation & Entrepreneurship (NACIE), the U.S. Department of Commerce announced today.Continue reading
- Pfizer will provide all its current and future patent-protected medicines and vaccines available in the U.S. or EU on a not-for-profit basis to 45 lower-income countries.
- Rwanda, Ghana, Malawi, Senegal and Uganda are the first five countries to commit to join the Accord. Health officials in these countries will help identify and resolve hurdles beyond supply to inform the roll out in all 45 lower-income countries.
- Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap and help create a healthier world for 1.2 billion people.
Grant Supports the Evaluation of the Syn-One Test® to Help Clinicians Determine More Precise Diagnoses of Dementias at Early Stages of Cognitive ImpairmentContinue reading
PHOENIX, Ariz. — May 18, 2022 — For cancer patients nearing the end of standard of care treatment, data gleaned from their tumor genome and tissue samples can be an invaluable resource for seeking out future care. But how do patients safely access these data and obtain analyses to guide future personalized care?
A unique study pairing researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, with one cancer patient is now underway to help answer that question. Rick Stanton, a former engineer and advanced prostate cancer patient, is at the center of TGen’s Patient Engagements, Operational Practices, and Laboratory Environment Standardization (PEOPLES) protocol.